Skip to content
20-F

Annual Report (Foreign)

REPLICEL LIFE SCIENCES INC.

0001062993-23-009854

← back to feed
Filed
May 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Apr 25, 2023 65M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −1.41M
Cash And Equivalents FY 2022 · Dec 31, 2022 413.03K
Stockholders Equity FY 2022 · Dec 31, 2022 −5.92M
Stockholders Equity FY 2022 · Dec 30, 2021 −6.84M
Current Liabilities FY 2022 · Dec 31, 2022 2.07M
Total Liabilities FY 2022 · Dec 31, 2022 6.71M
Current Assets FY 2022 · Dec 31, 2022 635.68K
Total Assets FY 2022 · Dec 31, 2022 798.22K
Eps Diluted FY 2022 · Dec 31, 2022 −0.02
Sga Expense FY 2022 · Dec 31, 2022 1.13M
Rd Expense FY 2022 · Dec 31, 2022 623.96K
Net Income FY 2022 · Dec 31, 2022 −743.23K
Operating Income FY 2022 · Dec 31, 2022 −1.4M